University of Pittsburgh Chancellor Patrick Gallagher’s efforts to hotwire the region’s fledgling life sciences industry is getting a spark from a new seed capital fund targeted to helping develop new medications.
The Pittsburgh Revolution Fund is soliciting $200 million, which will be made available in the form of investments in drug research teams with the idea of spinning out companies, said Bill Newlin, chairman, Newlin Investment Co., a seed-stage investment firm in Sewickley.
{iframe}http://www.post-gazette.com/business/healthcare-business/2017/05/30/university-of-pittsburgh-investment-fund-economic-development/stories/201705260186?utm_source=newsletter&utm_medium=email&utm_content=editors-picks-business-frontpage&utm_campaign=Headlines-Newsletter{/iframe}